TABLE 1.
Parameter | Bangladesh | Mexico | Peru | Egypt | Argentina | India | Nicaragua |
---|---|---|---|---|---|---|---|
Prevalence of ETEC (% of subjects) | 18 | 33 | 7.4 | 20 | 18.3 | 12-24 | 38 |
Toxin profile (% of subjects) | |||||||
ST | 50 | 19 | 31 | 53 | 40 | 32 | 32 |
LT/ST | 25 | 57 | 13 | 34 | 7 | 27 | 49 |
LT | 25 | 41 | 56 | 13 | 53 | 41 | 19 |
Prevalence of CF (%) | 56b | 21 | NT | 24 | 55 | 76 | 61 |
No. of subjects tested | 435a, 662b | 75c | 377d | 242e, 211f | 145g | 1,220h | 235i |
Data are from Bangladesh (24[a], 132[b]), Mexico (38[c]), Peru (19[d]), Egypt (1[e], 139[f]), Argentina (207[g]), India (180[h]), and Nicaragua (126[i]). NT, not tested.